An independent sponsor focused on the lower middle market
Since 2003, the Essex Partners (“EP”) principals have provided operational and financial support to lower middle market companies across a broad range of industries. EP was formed to invest in companies with defensible market positions, significant growth opportunities and sustainable competitive advantages.
Transaction Types
Essex Partners Completes Acquisition of ScarMD and Hematix for Platform Company SkinGenuity
Essex Partners, LLC, an independent sponsor and affiliate of Essex Capital Group, Inc., announced that it recently closed an add-on acquisition of a skincare product line that includes established, best-in-class scar (ScarMD) and bruise (Hematix) treatments. The acquisition will further diversify the product offering for Essex’s existing platform company, SkinGenuity, LLC.
United States
Investment Criteria
Financial
Revenues of $5 -$50 million; EBITDA margins of 10% or greater
Structure
Equity and mezzanine debt
Geography
United States
Ownership
Majority or minority equity participation
Investment Amounts
Typically, $2 -$20 million with capacity to finance larger investments